Skip to content

Depression: all studies

Page 652 of 1,034: studies 6,511 to 6,520 of 10,336, newest first. Back to the depression overview

Research

A multisite feasibility randomized clinical trial of mindfulness-based resilience training for aggression, stress, and health in law enforcement officers.

BMC Complementary Medicine and Therapies April 4, 2024 Michael Christopher, Sarah Bowen, Katie Witkiewitz et al. 9 citations

Law enforcement officers (LEOs) are exposed to significant stressors that can impact their mental health, increasing risk of posttraumatic stress disorder, burnout, at-risk alcohol use, depression, and suicidality. Compromised LEO health can subsequently lead to aggression and excessive use of force. Mindfulness training is a promising approach for high-stress populations and has been shown to...

Effect of yogic practices in the management of fibromyalgia: A review

Yoga Mimamsa April 3, 2024 Purnima Singh, Sobika Rao

Fibromyalgia (FM) is characterized by widespread pain, fatigue, stiffness, sleep irregularities, and tenderness of joints and muscles due to dysregulation of neurophysiological functions. It is more common in women compared to men. Till now, there is no specific treatment available for FM. The review aimed to review the literature on the effect of yogic practices on FM. The search was done in...

Effect of pranayama and mindfulness meditation on emotional distress and fatigue in adult hematological cancer patients undergoing chemotherapy

Yoga Mimamsa April 3, 2024 Anjali Mangesh Joshi, Suchitra Ajay Mehta, Nishad Gajanan Dhakate et al.

Introduction: Hematological cancer patients often experience anxiety, depression, and fatigue during chemotherapy. Addressing these issues can improve the quality of life and long-term well-being. This study evaluated the effects of pranayama and mindfulness meditation intervention on emotional distress and fatigue in hematological cancer patients undergoing chemotherapy. Materials and Methods:...

DOI: 10.4103/ym.ym_41_23 (opens in new tab) Full text (opens in new tab) Pranayama Emotion thermometer Emotional distress Fatigue assessment scale +2

Are first responders interested in psychedelics? Assessing previous use, interest, and willingness to participate in psychedelic-assisted therapy

Journal of Psychedelic Studies April 2, 2024 Sonia M. Brodie, Chelsea Stunden, Jay A. Olson et al.

AbstractBackground and aimsFirst responders such as firefighters and police officers often experience traumatic events as part of their work. As a result, they are more likely to have mental health issues such as post-traumatic stress disorder, depression, and anxiety compared to the general population. Psychedelic-assisted therapy has emerged as a promising avenue to alleviate these issues,...

Circuits for anesthesia, unawareness, OIRD, sleep and memory replay: MHb→IPN→PAG + DRN + MRN→claustrum→cortex.

April 1, 2024 Karin Vadovičová

Opiates are fast pain relievers that can cause respiratory arrest.I show new mechanisms how mu-opioids and high prenatal nicotine cause respiratory slowdownlinked to slow wave sleep. Mu-opioids activate the medial habenula which activates theinterpeduncular nucleus. The MHb-IPN system decreases respiration and alarm/arousal response tohypercapnia by projections to PAG, DRN, MRN and...

DOI: 10.14293/pr2199.000799.v1 (opens in new tab) Full text (opens in new tab) Claustrum Sleep system call Memory consolidation Hippocampus +1

A Meta-Analysis of fMRI Activation Studies of Ketamine in Healthy Participants

European Psychiatry April 1, 2024 J. H. Shepherd, Angela Hickman, Caitlin Baten et al.

Introduction There has been rapidly growing interest in understanding the pharmaceutical and clinical properties of psychedelic and dissociative drugs, with a particular focus on ketamine. This compound, long known for its anesthetic and dissociative properties, has garnered attention due to its potential to rapidly alleviate symptoms of depression, especially in individuals with...

A Cost-Effectiveness Analysis of a Ketamine-assisted Psychotherapy Program Compared to Online Group Psychotherapy in British Columbia, Canada

European Psychiatry April 1, 2024 V. Tsang

IntroductionDepression continues to present significant economic burdens to the Canadian healthcare system. Novel therapies, including those that incorporate psychoactive substances such as ketamine, present an opportunity to evaluate both clinical and economic effectiveness against current standards of care, which may be repeatedly proving ineffective in treating depression for some...

Rapid reduction of depressive symptoms with minimal dissociation: results from the KET01-02 and KET01-03 trials with oral prolonged-release (PR) ketamine KET01

European Psychiatry April 1, 2024 Christine Zu Eulenburg, Evangelos Papanastasiou, Karin Schmid et al.

IntroductionCurrent ketamine-based therapies for treatment-resistant depression (TRD) often induce dissociative effects. A novel oral PR ketamine formulation (KET01) results in a low and delayed peak concentration of ketamine, high hydroxynorketamine concentration, and is associated with limited dissociative properties.ObjectivesTo investigate efficacy, safety, and pharmacokinetics of KET01 in...

Psychedelika in der Psychiatrie

Nervenheilkunde April 1, 2024 Uwe Herwig 3 citations

ZUSAMMENFASSUNG Psychedelika stoßen in der Psychiatrie auf ein erneut zunehmendes fachliches und wissenschaftliches Interesse. Nach einer intensiveren Phase des Einsatzes im psychotherapeutischen Kontext Mitte des letzten Jahrhunderts kam die Forschung in dem Bereich nach gesetzlichen Verboten weitestgehend zum Erliegen. Erst seit wenigen Jahren wird das klinische Potenzial wieder mit modernen...

Für ein besseres Verständnis anhaltender Wahrnehmungsstörungen nach der Einnahme klassischer Psychedelika

Fortschritte der Neurologie · Psychiatrie April 1, 2024 Stefan Borgwardt, Tomislav Majić, Mihai Avram et al.

Klassische Psychedelika wie Psilocybin, Lysergsäurediethylamid (LSD), Ayahuasca oder 5-Methoxy-Dimethyltryptamin (5-MeO-DMT) stehen wieder vermehrt im Fokus des psychiatrisch-psychotherapeutischen und neurowissenschaftlichen Interesses. Dies ist vor allem auf aktuelle klinische Studien zurückzuführen, die einen möglichen therapeutischen Nutzen von Psychedelika in der Behandlung verschiedener...